Carbogen expands in Switzerland | Chemical & Engineering News
Volume 94 Issue 23 | p. 15 | Concentrates
Issue Date: June 6, 2016

Carbogen expands in Switzerland

Department: Business
Keywords: pharmaceutical chemicals, contract manufacturing, high potency, drug conjugates
[+]Enlarge
GEA’s Bubendorf facility, soon to be owned by Carbogen.
Credit: Carbogen
A photo of GEA’s Bubendorf facility, soon to be owned by Carbogen.
 
GEA’s Bubendorf facility, soon to be owned by Carbogen.
Credit: Carbogen

Drug chemical manufacturer Carbogen Amcis is adding to its operations in Bubendorf, Switzerland. There the company has agreed to acquire a GEA Pharma Systems site close to its current headquarters. The 3,360-m2 multistory building includes lab, small-scale production, storage, and office space. Carbogen intends to convert more of the facility into regulatory compliant operations for highly potent compound development. The company also plans to add manufacturing of antibody-drug conjugates.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment